Länder Analysen: Großbritannien
| 02.05.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.05.25 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.05.25 | London Stock Exchange (LSE) Buy | Goldman Sachs Group Inc. | |
| 02.05.25 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 02.05.25 | Rolls-Royce Buy | Deutsche Bank AG | |
| 02.05.25 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 02.05.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 02.05.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 02.05.25 | Linde Buy | Jefferies & Company Inc. | |
| 01.05.25 | Linde Neutral | UBS AG | |
| 01.05.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 01.05.25 | London Stock Exchange (LSE) Buy | Jefferies & Company Inc. | |
| 01.05.25 | Rolls-Royce Buy | UBS AG | |
| 01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | HSBC Sector Perform | RBC Capital Markets | |
| 01.05.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 01.05.25 | GSK Neutral | UBS AG | |
| 30.04.25 | Unilever Kaufen | DZ BANK | |
| 30.04.25 | GSK Neutral | UBS AG | |
| 30.04.25 | AstraZeneca Halten | DZ BANK | |
| 30.04.25 | HSBC Hold | Deutsche Bank AG | |
| 30.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.04.25 | GSK Hold | Jefferies & Company Inc. | |
| 30.04.25 | BP Buy | Goldman Sachs Group Inc. | |
| 30.04.25 | HSBC Buy | Goldman Sachs Group Inc. | |
| 30.04.25 | BP Overweight | Barclays Capital | |
| 30.04.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.04.25 | RELX Overweight | Barclays Capital | |
| 30.04.25 | HSBC Neutral | UBS AG | |
| 29.04.25 | BP Sector Perform | RBC Capital Markets | |
| 29.04.25 | BP Halten | DZ BANK | |
| 29.04.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.04.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 29.04.25 | BP Buy | Jefferies & Company Inc. | |
| 29.04.25 | BP Sector Perform | RBC Capital Markets | |
| 29.04.25 | BP Neutral | JP Morgan Chase & Co. | |
| 29.04.25 | HSBC Neutral | UBS AG | |
| 29.04.25 | BP Neutral | UBS AG | |
| 29.04.25 | AstraZeneca Buy | UBS AG | |